Multi-Dose Quadrivalent Influenza Vaccine

· Sanofi Pasteur

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Multi-Dose Quadrivalent Influenza Vaccine, covering 2022-04-25 to 2022-04-25. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety of a Multi-Dose Quadrivalent Influenza Vaccine [Phase 3]